Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 115

Related Citations for PubMed (Select 20954280)

1.

Peri-nuclear antibodies correlate with survival in Greek primary biliary cirrhosis patients.

Sfakianaki O, Koulentaki M, Tzardi M, Tsangaridou E, Theodoropoulos PA, Castanas E, Kouroumalis EA.

World J Gastroenterol. 2010 Oct 21;16(39):4938-43.

2.

Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis.

Itoh S, Ichida T, Yoshida T, Hayakawa A, Uchida M, Tashiro-Itoh T, Matsuda Y, Ishihara K, Asakura H.

J Gastroenterol Hepatol. 1998 Mar;13(3):257-65.

PMID:
9570238
3.

The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis.

Luettig B, Boeker KH, Schoessler W, Will H, Loges S, Schmidt E, Worman HJ, Gershwin ME, Manns MP.

J Hepatol. 1998 May;28(5):824-8.

PMID:
9625318
4.

The value of antinuclear antibodies in primary biliary cirrhosis.

Gao L, Tian X, Liu B, Zhang F.

Clin Exp Med. 2008 Mar;8(1):9-15. doi: 10.1007/s10238-008-0150-6. Epub 2008 Apr 3.

PMID:
18385935
5.

Anti-gp210 and anti-centromere antibodies are different risk factors for the progression of primary biliary cirrhosis.

Nakamura M, Kondo H, Mori T, Komori A, Matsuyama M, Ito M, Takii Y, Koyabu M, Yokoyama T, Migita K, Daikoku M, Abiru S, Yatsuhashi H, Takezaki E, Masaki N, Sugi K, Honda K, Adachi H, Nishi H, Watanabe Y, Nakamura Y, Shimada M, Komatsu T, Saito A, Saoshiro T, Harada H, Sodeyama T, Hayashi S, Masumoto A, Sando T, Yamamoto T, Sakai H, Kobayashi M, Muro T, Koga M, Shums Z, Norman GL, Ishibashi H.

Hepatology. 2007 Jan;45(1):118-27.

PMID:
17187436
6.

Differential detection of nuclear envelope autoantibodies in primary biliary cirrhosis using routine and alternative methods.

Tsangaridou E, Polioudaki H, Sfakianaki R, Samiotaki M, Tzardi M, Koulentaki M, Panayotou G, Kouroumalis E, Castanas E, Theodoropoulos PA.

BMC Gastroenterol. 2010 Mar 8;10:28. doi: 10.1186/1471-230X-10-28.

7.

Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study.

Miyachi K, Hankins RW, Matsushima H, Kikuchi F, Inomata T, Horigome T, Shibata M, Onozuka Y, Ueno Y, Hashimoto E, Hayashi N, Shibuya A, Amaki S, Miyakawa H.

J Autoimmun. 2003 May;20(3):247-54.

PMID:
12753810
8.

[Clinical manifestation and autoantibody profile in 123 patients with primary biliary cirrhosis].

Liu HH, Fu JL, Xu J, Luo SQ, Liu ZW, Wang FS.

Beijing Da Xue Xue Bao. 2013 Apr 18;45(2):233-7. Chinese.

9.

Antibody titer to gp210-C terminal peptide as a clinical parameter for monitoring primary biliary cirrhosis.

Nakamura M, Shimizu-Yoshida Y, Takii Y, Komori A, Yokoyama T, Ueki T, Daikoku M, Yano K, Matsumoto T, Migita K, Yatsuhashi H, Ito M, Masaki N, Adachi H, Watanabe Y, Nakamura Y, Saoshiro T, Sodeyama T, Koga M, Shimoda S, Ishibashi H.

J Hepatol. 2005 Mar;42(3):386-92.

PMID:
15710222
10.

Increased expression of nuclear envelope gp210 antigen in small bile ducts in primary biliary cirrhosis.

Nakamura M, Takii Y, Ito M, Komori A, Yokoyama T, Shimizu-Yoshida Y, Koyabu M, Matsuyama M, Mori T, Kamihira T, Daikoku M, Migita K, Yatsuhashi H, Nozaki N, Shimoda S, Ishibashi H.

J Autoimmun. 2006 Mar;26(2):138-45. Epub 2005 Dec 6.

PMID:
16337775
11.

Primary biliary cirrhosis-specific autoantibodies in first degree relatives of Greek primary biliary cirrhosis patients.

Zografos TA, Gatselis N, Zachou K, Liaskos C, Gabeta S, Koukoulis GK, Dalekos GN.

World J Gastroenterol. 2012 Sep 14;18(34):4721-8.

12.

Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis.

Muratori P, Muratori L, Ferrari R, Cassani F, Bianchi G, Lenzi M, Rodrigo L, Linares A, Fuentes D, Bianchi FB.

Am J Gastroenterol. 2003 Feb;98(2):431-7.

PMID:
12591064
13.

Optimized detection of circulating anti-nuclear envelope autoantibodies by immunofluorescence.

Tsiakalou V, Tsangaridou E, Polioudaki H, Nifli AP, Koulentaki M, Akoumianaki T, Kouroumalis E, Castanas E, Theodoropoulos PA.

BMC Immunol. 2006 Sep 6;7:20.

14.

Antimitochondrial antibody-negative primary biliary cirrhosis: a subset of primary biliary cirrhosis.

Liu B, Shi XH, Zhang FC, Zhang W, Gao LX.

Liver Int. 2008 Feb;28(2):233-9. doi: 10.1111/j.1478-3231.2007.01651.x.

PMID:
18251980
15.

High prevalence of primary biliary cirrhosis and disease-associated autoantibodies in Japanese patients with systemic sclerosis.

Imura-Kumada S, Hasegawa M, Matsushita T, Hamaguchi Y, Encabo S, Shums Z, Norman GL, Takehara K, Fujimoto M.

Mod Rheumatol. 2012 Nov;22(6):892-8. doi: 10.1007/s10165-012-0607-z. Epub 2012 Feb 12.

PMID:
22327744
16.

Primary biliary cirrhosis-related autoantibodies in a large cohort of italian patients with systemic sclerosis.

Cavazzana I, Ceribelli A, Taraborelli M, Fredi M, Norman G, Tincani A, Satoh M, Franceschini F.

J Rheumatol. 2011 Oct;38(10):2180-5. doi: 10.3899/jrheum.110167. Epub 2011 Sep 15.

PMID:
21921093
17.

[Diagnostic significance of autoantibodies in patients with primary biliary cirrhosis].

Xiao H, Chen JW, Xie X, Liu YM, Li F.

Beijing Da Xue Xue Bao. 2012 Apr 18;44(2):209-14. Chinese.

18.

Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.

Granito A, Muratori P, Muratori L, Pappas G, Cassani F, Worthington J, Ferri S, Quarneti C, Cipriano V, de Molo C, Lenzi M, Chapman RW, Bianchi FB.

Aliment Pharmacol Ther. 2007 Sep 15;26(6):831-8.

19.
20.

Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity.

Orth T, Gerken G, Meyer Zum B├╝schenfelde KH, Mayet WJ.

Z Gastroenterol. 1997 Feb;35(2):113-21.

PMID:
9066101
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk